| MOG encephalomyelitis: international recommendations on diagnosis and antibody testing |
50 |
| Autoantibody-associated schizophreniform psychoses: pathophysiology, diagnostics, and treatment |
12 |
| Autoantibody-associated schizophreniform psychoses: clinical symptomatology |
11 |
| Certification criteria for stroke units in Germany. Update 2018 |
11 |
| Characteristics and dynamics of inpatient treatment of patients with Parkinson's disease in Germany. Analysis of 1.5 million patient cases from 2010 to 2015 |
7 |
| Internet-based self-management interventions. Quality criteria for their use in prevention and treatment ofmental disorders |
6 |
| Psychosocial care of refugees in Germany. Insights from the emergency relief and development aid |
5 |
| Internet andmobile-assisted interventions in mental disorders. Implementation in Germany from an ethical perspective |
5 |
| Innovative psychotherapy research: towards an evidence-based and process-based individualized and modular psychotherapy |
5 |
| Breakthrough in understanding the molecular causes of psychiatric disorders |
4 |
| Stigma - risk factor and consequence of suicidal behavior. Implications for suicide prevention |
4 |
| Therapy drop-out as a predictor of re-delinquency. Legal probation of substance addicted patients according to 64 of the German Legal Code |
4 |
| Provision of palliative care for people with advanced dementia |
4 |
| Autoimmune encephalitis with psychotic symptoms. Diagnostics, warning signs and practical approach |
4 |
| Forensic preventive assertive community treatment. Pilot project to prevent violent crimes in the context of psychiatric disorders |
4 |
| Specific components for integrative and flexible care models according to 64b SGB V |
4 |
| Mental health among physicians Burnout, depression, anxiety and substance abuse in the occupational context |
4 |
| Alzheimer dementia: course and burden on caregivers. Data over 18 months from German participants of the GERAS study |
3 |
| Psychotherapy of depressive disorders. Procedures, evidence and perspectives |
3 |
| Antipsychotic-inducedmotor symptoms in schizophrenic psychoses-Part 2. Catatonic symptoms and neuroleptic malignant syndrome |
3 |
| Frequency of coercivemeasures as a quality indicator for psychiatric hospitals? |
3 |
| Treatment of chronic migraine with botulinum neurotoxin A. Expert recommendations of the German Migraine and Headache Society |
3 |
| Update on anti-N-methyl-D-aspartate receptor encephalitis |
3 |
| Classification accuracy of the symptom validity tests Word Memory Test and the German version of the Structured Inventory of Malingered Symptomatology |
3 |
| ADHD in adult patients with substance use disorders |
3 |
| Prevention of cognitive decline and dementia by treatment of risk factors |
3 |
| Attitudes towards psychotherapy in South Korea and Germany. A cross-cultural comparative study |
3 |
| Current concepts of resilience research |
3 |
| Poverty, migration and mental health |
2 |
| Diagnostics and conservative treatment of cervical and lumbar spinal stenosis |
2 |
| Neurological side effects of checkpoint inhibitors |
2 |
| Self-assessment of treatment urgency on presentation to a neurological emergency department. Results of a patient survey |
2 |
| Genuine motor phenomena in schizophrenia. Neuronal correlates and pathomechanisms |
2 |
| Course and complications of GHB detoxification treatment: a 1-year case series |
2 |
| Impairments of language and communication in schizophrenia |
2 |
| Did Alzheimer research fail entirely? Failure of amyloid-based clinical studies |
2 |
| The career of the psychiatrist Dietfried Muller-Hegemann (1910-1989). Example of a politically motivated rise and fall in the German Democratic Republic |
2 |
| Enhancingmonitoring of disease progression-remote sensoring in multiple sclerosis |
2 |
| Rabies and Bornavirus encephalitis. Fatal emerging viral encephalitis-a potential problem for organ recipients |
2 |
| Conversions of cognitive screenings. Mini-Mental State Examination vs. Montreal Cognitive Assessment vs. DemTect |
2 |
| MRI alterations in immunomodulation |
2 |
| Unmet needs of family dementia caregivers of persons with dementia. Primary medical care |
2 |
| Long-term efficacy of multimodal pain therapy for chronic back pain |
2 |
| Antisense therapies for neurological diseases |
2 |
| Gene therapies for neuromuscular diseases |
2 |
| Transition from neuropediatrics to neurology in neuromuscular diseases |
2 |
| Children of mentally ill parents. Also a topic in the context of child protection |
2 |
| Diagnosis of irreversible loss of brain function (brain death)-what is new? |
2 |
| Quality of life and disability after severe stroke and early neurological rehabilitation |
2 |
| Integrated neurorehabilitation improves efficacy of treatment |
2 |
